Chipscreen Biosciences, Ltd.

Quick facts

Phase 3 pipeline

• Chiauranib · Other

Phase 2 pipeline

• chiglitazar sodium tablets

Phase 1 pipeline

• adriacin · Oncology
• CS12192 capsule
• CS231295
• CS23546
• CS32582 capsule
• CS32582 capsule（high dose）
• CS32582 capsule（low dose）
• CS32582 capsule（medium dose）
• NWY001

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Chipscreen Biosciences, Ltd. portfolio CI brief
• Chipscreen Biosciences, Ltd. pipeline updates RSS